Studies have demonstrated that PLC has various intricate and diverse alterations involving somatic mutations, DNA copy number variations (CNVs), a high degree of aneuploidy, and epigenetic variations, which all lead to varying degrees of HCC 4. The gene discussed is HSPG2; the disease is hepatocellular carcinoma.